Cardiogen Overview, Dosing & Safety | Peptide Database

Cardiogen (AEDR)

AEDR | Cardiovascular Bioregulator Peptide

Community Research

Join others researching Cardiogen — share findings, ask questions, and learn from real experiences

Cardiogen is a Khavinson bioregulator peptide consisting of four amino acids, derived from heart tissue research. Unlike larger peptides that work on cell surfaces, Cardiogen penetrates directly to the cell nucleus where it binds to specific DNA regions to regulate gene expression. This epigenetic mechanism supports tissue repair and improves cardiovascular function, particularly benefiting the heart and blood vessels.

Cardiogen works through epigenetic regulation by penetrating cell nuclei and interacting with specific DNA regions, histones, and nucleosomes. It regulates which genes are activated or suppressed without changing DNA sequence. This mechanism supports cardiac tissue repair, enhances myocardial function, and improves cardiovascular tissue regeneration by influencing gene expression in heart cells.

Molecular Data

Alanine

Position 1

Glutamic Acid

Position 2

Aspartic Acid

Position 3

Arginine

Position 4

Research Indications

Supports heart tissue repair through gene expression regulation at the nuclear level.

May improve overall myocardial function and cardiac performance.

Addresses age-related cardiovascular decline through bioregulation.

Influences gene expression to support tissue repair without altering DNA sequence.

Promotes cardiac tissue regeneration at the cellular level.

Dosing Protocols

Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles, often repeated 2-3 times per year.

Standard protocol

10-20 mg

Daily for 10-20 days

Oral capsules

Maintenance

10 mg

2-3 cycles yearly

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Generally well-tolerated

Minimal side effects reported

Stop Signs - Discontinue if:

Allergic reactions

Unusual cardiac symptoms

Contraindications

Active cardiac emergencies (seek medical care)

Known hypersensitivity

Pregnancy or breastfeeding

Quality Checklist

Good Signs

White powder or capsules

Clear solution if reconstituted

Proper packaging and labeling

Warning Signs

Unknown source or purity

Bad Signs

Discoloration

Unusual odor

Damaged packaging

Frequently Asked Questions

How does Cardiogen improve cardiac function if it's just 4 amino acids?

Cardiogen's short tetrapeptide (AEDR) penetrates directly into cell nuclei where it regulates cardiac gene expression epigenetically. Despite being only 4 amino acids, this structure is sufficient for DNA binding and histonemodulation, allowing it to influence which genes are activated in heart tissue without altering DNA sequence itself.

Can Cardiogen help after a heart attack or cardiac event?

Cardiogen's mechanism supports post-cardiac event recovery by promoting cardiac tissue repair and myocardial function improvement through gene expression modulation. However, no clinical human data exists on cardiac event recovery. This remains theoretical based on mechanisms and traditional use in Russian medicine.

Is Cardiogen safe for people with existing heart conditions?

Cardiogen is well-tolerated with minimal side effects reported. People with cardiac conditions should consult healthcare providers before use. Active cardiac emergencies require immediate medical care, not peptide therapy. For chronic cardiovascular support, medical supervision is prudent.

How often should I cycle Cardiogen for heart health maintenance?

Standard protocol is 10-20 day cycles repeated 2-3 times yearly for cumulative cardiovascular benefits. Effects persist between cycles due to epigenetic changes. Some users perform cycles seasonally, while others maintain 2-3 yearly cycles consistently for long-term cardiac tissue support and age-related decline prevention.

References

Short peptides can penetrate nuclei, interact with DNA and histones to regulate gene expression.

Demonstrated effects on cardiac tissue through gene expression modulation.

Comprehensive review of bioregulator peptides and their epigenetic mechanisms.

Related Peptides

Complementary cardiovascular bioregulators - Cardiogen for heart, Vesugen for vessels.

Often combined in comprehensive anti-aging Khavinson protocols.

Different organ targets; can be used in comprehensive bioregulator protocols.

Part of Khavinson bioregulator family; targets different tissue.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.